Monday, December 30, 2019 1:39:40 PM
This product does seem to have merit, and I know lots of products have gone unnoticed ... or suppressed for extended periods of time but this has been a long long haul with no progress.
That said I will repeat a couple of questions that one of the more brilliant posters slammed in the past as ignorant , thereby showing his own lack of knowledge.
Universities across the country including publicly funded ones are aggressively pursuing patentable research, many have the funding to pursue fda approval... or put together a group that does.
I can say I’d be thrilled if the Executives at guided therapeutics traded 40% -50% of the company to University of——— teaching hospital in exchange for conducting the required fda trials.
The positive impact of collaboration with a reputable institution alone would increase demand (= $) for the stock—- it would beat the hell out of the dilution used in the past to raise funds.
Has this been explored, and if not why?
Women’s health advocacy groups should be all over asking questions of public health officials to investigate and report on the validity of this product. Again, raising awareness and scrutiny will speed up all f us knowing if it is a valid product or not.
Like most of you longer term folks, my current stock value is small fraction of my investment, so selling out at this stage is pretty pointless, so it really needs to show real promise and start climbing out of the hole or go ahead and shut the doors. Permanently riding the bankruptcy line is a waste of everyone’s time.
Recent GTHP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:36:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 06:42:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:48:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 04:24:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 09:49:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2023 04:44:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 07:53:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:00:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM